Search

everythinglearnresearchcommunity

for

Search:↓

Silver nanoparticles from Mitracarpus scaber protect the liver and reduce prostate enlargement.

Cuscuta reflexa extract may help treat benign prostatic hyperplasia by reducing inflammation and oxidative stress.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

CEC levels may be a useful marker for predicting prostate cancer progression.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

There is no link between hair loss and prostate enlargement.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Large prostate patients more likely to have hair loss.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

All treatments helped with prostate symptoms, but the combination of dibenyline and finasteride worked best without extra side effects.

Finasteride helps with prostate symptoms but may cause sexual side effects.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Kolaviron and quercetin may help treat prostate issues.